Page last updated: 2024-10-31

midazolam and Peritoneal Neoplasms

midazolam has been researched along with Peritoneal Neoplasms in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Peritoneal Neoplasms: Tumors or cancer of the PERITONEUM.

Research Excerpts

ExcerptRelevanceReference
"We present a patient with peritoneal carcinosarcoma who was treated with the alkylating agent ifosfamide and experienced a rapid decline in mental status."4.90Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature. ( Friedman, D; Racela, R; Taupin, D, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taupin, D1
Racela, R1
Friedman, D1

Reviews

1 review available for midazolam and Peritoneal Neoplasms

ArticleYear
Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.
    Clinical EEG and neuroscience, 2014, Volume: 45, Issue:3

    Topics: Carcinosarcoma; Cerebral Cortex; Diagnosis, Differential; Electroencephalography; Epilepsy, Generali

2014